This study will evaluate the referral to harm reduction services (HRS) including syringe services, naloxone overdose prevention, substance use treatment referral, HIV, HCV, and STD testing and referral and linkage to care through capacity building of existing programs through client services data.
This is a prospective longitudinal Type 1 Hybrid Implementation Effectiveness Study on the expansion of harm reduction services for people who inject drugs (PWID) and people who use opioids (PWUO) residing in high risk areas of rural southern Illinois. This study record describes one component of the larger Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC) study Community Response Plan (CRP) framework, specifically the expansion of harm reduction services intervention (HRS). The aim is to assess the effectiveness of expansion of evidenced based harm reduction services through our CRP framework comprising: a) geographically targeted recruitment based on hot spot and vulnerability analyses, b) community engagement, c) recruitment via Respondent Driven Sampling (RDS), d) expanded surveillance for HIV and HCV, and e) concomitant HCV and opioid use treatment capacity expansion through the Extension of Community Healthcare Outcomes (ECHO) model. Examination of facilitators and barriers impacting implementation of service delivery is evaluated through mixed methods process evaluation. The Type 1 Hybrid design is supported by conditions including the existing evidence based for benefits and minimal harm of "harm reduction services" and strong base for applicability of this intervention in the study setting (ie rural opioid use)
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
306
Participants are referred to harm reduction services
Southern Illinois University
Carbondale, Illinois, United States
The Community Action Place, Inc.
Murphysboro, Illinois, United States
Total Participants Who Received Referrals to the Harm Reduction Services Organization
Number of participants who accept referral to the intervention (divided by the total enrolled who did not have previous engagement prior to the study with the harm reduction services organization).
Time frame: 2 years
Number of Locations Where Participants Received Most of Syringes or Needles
Number of unique zip codes that participants received most of their syringes or needles based on mobile unit delivery.
Time frame: 2 years
Number of Times Sterile Syringes and/or Equipment Obtained From an Intervention
This was counted as the number of visits made by the hard reduction service organization to distribute sterile syringes and/or equipment.
Time frame: 2 years
Number of Times Participants Used a Syringe or Needle That They Knew Was Used by Somebody Else
"How many times (encounters) in the past 30 days did you inject using a syringe or needle that you know had been used by somebody else?"
Time frame: 2 years
Number of Times Participants Used a Cotton, Cooker, Spoon, or Water for Rinsing or Mixing That They Knew Was Used by Somebody Else
"How many times (encounters) in the past 30 days did you use a cotton, cooker, spoon or water for rinsing or mixing that you know had been used by somebody else?"
Time frame: 2 years
Number of Times Participants Let Someone Else Use a Cotton, Cooker, Spoon, or Water for Rinsing or Mixing After They Used it
"How many times (encounters) in the past 30 days did you let someone else use a cotton, cooker, spoon, or water for rinsing or mixing after you used it?"
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 2 years
Number of Participants With Drive Time Less Than 30 Minutes to Nearest Syringe or Needle Exchange
Number of participants with drive time less than 30 minutes to nearest syringe or needle exchange.
Time frame: 2 years
Number of Participants That Currently Have Naloxone
"Do you currently have naloxone or Narcan with you or at home?"
Time frame: 2 years
Number of Participants Who Received Substance Use Disorders (SUD) Treatment Referrals
Total number of participants who received a substance use disorder referrals made by the hard reduction services organization.
Time frame: 2 years
Total Number of Participants Who Received an HIV Screening
Total number of tests that participants screened for HIV, from baseline to follow-up.
Time frame: 2 years
Total Number of Participants Who Received an HCV Screening
Total participants screened for HCV at least once during baseline and follow-up. For those who had a HCV reactive test were then later referred to further services.
Time frame: 2 years
Number of Participants With Knowledge of PrEP
"Have you ever heard of medicine people can take to prevent HIV?"
Time frame: 6 months
Number of Participants Diagnosed With HIV Who Have Access to HIV Care
Total number of participants who were newly diagnosed with HIV during the study period.
Time frame: 2 years
Number of Participants Diagnosed With HCV Who Have Access to HCV Care
Total number of participants who were newly diagnosed with chronic Hep C who were referred to Hep C care.
Time frame: 2 years
Number of Times a Participant Engaged in Condomless Sex (Vaginal or Anal)
"In the last 30 days, how many times did you have vaginal or anal sex without a condom?"
Time frame: 6 months